BioCentury
ARTICLE | Clinical News

Lexgenleucel-T: Phase I/II data

February 16, 2009 8:00 AM UTC

Data from an ongoing, open-label Phase I/II trial in 12 HIV-1 infected patients fully suppressed on antiretroviral treatments showed that VRX496-transduced CD4+ T cells traffic to gut lymphoid tissue ...